204
Participants
Start Date
March 1, 2023
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
TMF
switch ETV to TMF
RECRUITING
The Second Affiliated Hospital of Chongqing Medical University, Chongqing
NOT_YET_RECRUITING
Chongqing University Three Gorges Central Hospital, Chongqing
NOT_YET_RECRUITING
Affiliated Hospital of Guangxi Medical University, Guangxi
NOT_YET_RECRUITING
Hepatobiliary disease of Jilin Province, Jilin
NOT_YET_RECRUITING
The First People's Hospital of Yunnan Province, Kunming
NOT_YET_RECRUITING
the Second People's Hospital of Yunnan Province, Kunming
NOT_YET_RECRUITING
Nanjing Second Hospital, Nanjing
RECRUITING
The Second Hospital of Ningbo, Ningbo
RECRUITING
Shanghai East Hospital, Shanghai
NOT_YET_RECRUITING
Shuguang Hospital, Shanghai, China., Shanghai
NOT_YET_RECRUITING
The Sixth People's Hospital of Shenyang, Shenyang
NOT_YET_RECRUITING
The First People's Hospital of Taicang, Taicang
NOT_YET_RECRUITING
The Fourth People's Hospital of Zibo, Zibo
Collaborators (1)
Jiangsu Hansoh Pharmaceutical Co., Ltd.
INDUSTRY
The Second Affiliated Hospital of Chongqing Medical University
OTHER